The expected protective effect of tumour infiltration by NK cells is lost during TGFβ-mediated epithelial–mesenchymal transition (EMT), and inhibitors of this pathway promote control of epithelial-derived tumours in pre-clinical models. Here, TGFB1 is linked to neoplasm.